Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04SQY
|
||||
| Former ID |
DIB019715
|
||||
| Drug Name |
deoxycorticosterone
|
||||
| Synonyms |
11-deoxycorticosterone; 21-hydroxyprogesterone
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H30O3
|
||||
| InChI |
InChI=1S/C21H30O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h11,15-18,22H,3-10,12H2,1-2H3/t15-,16-,17-,18+,20-,21-/m0/s1
|
||||
| InChIKey |
ZESRJSPZRDMNHY-YFWFAHHUSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
6081, 841768, 855538, 3136426, 6435811, 6436728, 7885076, 8144739, 8153870, 11466985, 11468105, 11486839, 12146618, 14753185, 24702312, 24894056, 26737269, 29225165, 47275752, 47573556, 48094736, 48243599, 49699039, 49960527, 50103900, 53788533, 56412749, 56424139, 57323229, 57392893, 80433608, 81062004, 81093225, 85165316, 85787368, 92125920, 92298674, 96024489, 103556916, 103914536, 104311286, 109658567, 121363591, 124801181, 125003832, 126522953, 126651375, 127337403, 127337404, 127342267
|
||||
| Target and Pathway | |||||
| Target(s) | mRNA of glucocorticoid receptor | Target Info | Agonist | [2] | |
| Mineralocorticoid receptor | Target Info | Agonist | [3] | ||
| KEGG Pathway | Neuroactive ligand-receptor interactionhsa04960:Aldosterone-regulated sodium reabsorption | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TCR Signaling Pathway | |||||
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| FOXA2 and FOXA3 transcription factor networks | |||||
| Glucocorticoid receptor regulatory network | |||||
| Regulation of Androgen receptor activity | |||||
| AP-1 transcription factor network | |||||
| PathWhiz Pathway | Kidney Function | ||||
| Reactome | BMAL1:CLOCK,NPAS2 activates circadian gene expression | ||||
| WikiPathways | Serotonin Receptor 4/6/7 and NR3C Signaling | ||||
| SIDS Susceptibility Pathways | |||||
| Endoderm Differentiation | |||||
| Hair Follicle Development: Cytodifferentiation (Part 3 of 3) | |||||
| Adipogenesis | |||||
| Circadian Clock | |||||
| Nuclear ReceptorsWP554:ACE Inhibitor Pathway | |||||
| References | |||||
| REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2871). | ||||
| REF 2 | Functional probing of the human glucocorticoid receptor steroid-interacting surface by site-directed mutagenesis. Gln-642 plays an important role in steroid recognition and binding. J Biol Chem. 2000Jun 23;275(25):19041-9. | ||||
| REF 3 | Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur J Pharmacol. 1993 Oct 15;247(2):145-54. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.